Mundipharma
Tom Benton is an accomplished finance professional with extensive experience in leadership roles spanning over two decades at notable companies such as Mundipharma and GSK. Currently serving as Senior Director of Finance Systems Intelligence & Simplification at Mundipharma since September 2023, Benton previously held the position of Senior Director Finance, Scientific Affairs & Business Development at the same company, where notable achievements included developing a budget presentation that gained endorsement from senior executives. At GSK, Benton held various key roles, including Head of Global Reporting Centre of Excellence, where leadership of a diverse team contributed to significant data-driven decision-making enhancements. Education includes a Bachelor's degree in Economics from the University of Bristol and qualification as a Chartered Accountant from ICAEW. Prior experience also includes working as an Audit Senior at Arthur Andersen & Co.
This person is not in any teams
This person is not in any offices
Mundipharma
5 followers
The Mundipharma global network of independent associated companies shares a common purpose to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned, the network has a presence in over 120 countries. In Europe, the network employees more than 2,000 employees from R&D to manufacturing & supply and commercial, and with revenues in excess of €1 billion. At Mundipharma we strive for one high performing and learning environment where individuals can make a real difference. We have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think that we see what others don’t by challenging conventional wisdom and asking different and challenging questions. By working in partnership with all our stakeholders, the Mundipharma network develops medicines that create value for patients, payers and wider healthcare systems. We have built a European portfolio of medicines to create value for patients, payers and wider healthcare systems across important therapeutic areas such as diabetes, respiratory, oncology, pain and biosimilars.